Healthcare Services

Epidural abscess treatment market forecast to reach $62.27B by 2030

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Epidural Abscess Treatment Market Expected To Change From 2026 To 2030?

The epidural abscess treatment market has shown strong expansion in recent years. It is projected to increase from $43.78 billion in 2025 to $46.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.4%. The growth observed in prior periods can be attributed to elements such as the frequency of spinal infection, the dangers posed by delayed diagnosis, the accessibility of antibiotics, the capacity of hospital neurosurgery departments, and the wider infectious disease burden.

The epidural abscess treatment market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $62.27 billion, demonstrating a compound annual growth rate (CAGR) of 7.5%. This projected growth throughout the forecast period stems from factors such as enhanced access to advanced imaging, the implementation of early intervention protocols, ongoing antimicrobial innovations, the expansion of hospital infrastructure, and heightened clinician awareness. Key developments expected during this period include a greater emphasis on early diagnostic imaging, an increasing dependence on broad-spectrum antibiotics, an uptick in surgical intervention rates, the broadening of hospital-based infection care services, and a concentrated effort on averting neurological complications.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/epidural-abscess-treatment-global-market-report

Which Key Factors Are Driving The Epidural Abscess Treatment Market Growth?

The growing occurrence of neurological conditions is anticipated to drive expansion in the epidural abscess treatment market. These are health issues impacting the nervous system, encompassing the brain, spinal cord, and nerves. Examples of such disorders include acute spinal cord injury, Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS), among others. Treatment for epidural abscess, applied in cases of neurological disorders, consists of immediate surgical drainage of the abscess and antibiotic therapy to avert compression of the spinal cord and nerves, thereby alleviating pressure. An illustration from April 2025 by the Alzheimer’s Association, a US-based nonprofit, indicates that by 2025, 7.2 million individuals aged 65 and above will be living with Alzheimer’s disease. Additionally, the yearly expenses for attending to individuals with Alzheimer’s and other forms of dementia (excluding unpaid care) are forecasted to reach $384 billion in 2025. Consequently, the rising incidence of neurological conditions is fueling the expansion of the epidural abscess treatment market.

How Are Segments Identified Within The Epidural Abscess Treatment Market Segment Framework?

The epidural abscess treatment market covered in this report is segmented –

1) By Type: Intracranial, Intraspinal

2) By Treatment: Antifungal, Antibiotics, Surgery

3) By End-User: Hospital, Pharmacy, Specialty Clinics, Other End-Users

Subsegments:

1) By Intracranial: Brain Abscess, Subdural Abscess, Epidural Abscess in the Cranium

2) By Intraspinal: Cervical Epidural Abscess, Thoracic Epidural Abscess, Lumbar Epidural Abscess, Sacral Epidural Abscess

Who Are The Companies Competing Within The Epidural Abscess Treatment Market?

Major companies operating in the epidural abscess treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Kyowa Hakko Kirin Co. Ltd., Hikma Pharmaceuticals plc, Intas Pharmaceuticals Limited, Alembic Limited, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals

Get The Full Epidural Abscess Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/epidural-abscess-treatment-global-market-report

Which Region Leads The Epidural Abscess Treatment Market In Terms Of Market Share?

North America was the largest region in the epidural abscess treatment market in 2025. The regions covered in the epidural abscess treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Epidural Abscess Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/epidural-abscess-treatment-global-market-report

Browse Through More Reports Similar to the Global Epidural Abscess Treatment Market 2026, By The Business Research Company

Appendicitis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/appendicitis-treatment-global-market-report

Epidural Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/epidural-catheter-global-market-report

Epidural Anesthesia Disposable Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/epidural-anesthesia-disposable-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795